The market for molecular diagnostics is valued at almost 18 billion US dollars and it is doubtless that the COVID-19 pandemic has triggered not only tremendous developmental activities but has also ramped-up distribution activities of diagnostics around the globe. So, no need for us to explain to anyone any more what RNA-based tests are.
Although therapeutics in dermatology are leading the list of best-selling drugs worldwide, molecular diagnostics in dermatology is still a sleeping giant. We realized that #dermatology is becoming a focus at MEDICA, but there is still a lot to do!
At our first presence at a trade fair, we showed our visitors how Dermagnostix targets unmet diagnostic needs and received a lot of positive feedback for our booth and our solution. Above all, meeting old friends and making new ones, was anyhow the best part.